Enovix (NASDAQ:ENVX) Releases Q3 2026 Earnings Guidance

Enovix (NASDAQ:ENVX) updated its third quarter 2026 earnings guidance on Monday. The company provided earnings per share guidance of -0.140–0.140 for the period, compared to the consensus EPS estimate of -0.160. The company issued revenue guidance of $11.0 million, compared to the consensus revenue estimate of $9.5 million.

Analyst Ratings Changes

ENVX has been the topic of a number of research analyst reports. Wall Street Zen raised shares of Enovix from a “strong sell” rating to a “sell” rating in a research report on Sunday. Bank of America reiterated a “neutral” rating and issued a $5.00 target price on shares of Enovix in a research report on Monday, August 17th. B. Riley Financial cut their target price on shares of Enovix from $10.00 to $9.00 and set a “buy” rating for the company in a research report on Thursday, August 13th. Weiss Ratings reissued a “sell (e+)” rating on shares of Enovix in a research note on Friday, October 2nd. Finally, TD Cowen upgraded shares of Enovix to a “hold” rating in a report on Monday, October 5th. One analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, three have assigned a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $11.77.

Enovix Stock Performance

Shares of ENVX stock opened at $2.59 on Tuesday. Enovix has a fifty-two week low of $2.40 and a fifty-two week high of $14.21. The stock’s 50-day moving average is $3.33 and its two-hundred day moving average is $5.09. The company has a debt-to-equity ratio of 2.46, a current ratio of 9.71 and a quick ratio of 9.37. The firm has a market cap of $568.37 million, a P/E ratio of -3.20 and a beta of 2.49.

Enovix (NASDAQ:ENVX) last announced its quarterly earnings results on Wednesday, August 12th. The company reported ($0.13) EPS for the quarter, beating the consensus estimate of ($0.15) by $0.02. Enovix had a negative return on equity of 64.50% and a negative net margin of 473.89%. The business had revenue of $9.02 million during the quarter, compared to analysts’ expectations of $8.43 million. During the same quarter in the previous year, the business posted ($0.13) EPS. The firm’s quarterly revenue was up 20.8% compared to the same quarter last year. Enovix has set its Q3 2026 guidance at -0.170–0.130 EPS. Analysts predict that Enovix will post -0.80 earnings per share for the current fiscal year.

Key Enovix News

Here are the key news stories impacting Enovix this week:

• Positive Sentiment: Preliminary Q3 revenue reached approximately $11 million, up 38% year over year and above the company’s $11 million guidance and the roughly $9.5 million analyst consensus. The results suggest Enovix is continuing to expand commercial shipments. Enovix Q3 Preliminary Revenue Rises 38%
• Positive Sentiment: Defense demand and an expanding customer pipeline were highlighted as growth drivers. Investors may view increased defense-sector interest as validation for Enovix’s battery technology and a potential source of future orders. Enovix reports $11 million Q3 revenue
• Positive Sentiment: The company’s updated third-quarter outlook called for revenue of $11 million and an EPS loss of approximately $0.14, both better than consensus estimates of $9.5 million and a $0.16 loss, respectively. Enovix Q3 Revenue Rises 38% to $11 Million, Exceeding Guidance as Defence Demand Grows
• Neutral Sentiment: Market coverage noted that ENVX shares gained early in the session, reflecting the favorable preliminary revenue update; however, the stock remains highly volatile and well below its longer-term moving averages. US Stocks Mixed; Enovix Shares Jump
• Negative Sentiment: Wall Street Zen recently downgraded Enovix to “Sell,” underscoring continuing concerns about profitability, execution and the company’s substantial cash needs despite the improved revenue outlook. Enovix Raised to Sell at Wall Street Zen

Enovix Company Profile

Enovix Corporation is a battery technology company developing lithium-ion batteries that use a silicon-based anode and a three-dimensional cell architecture. The company’s design is intended to increase energy density while incorporating structural features designed to improve safety and cycle life compared with conventional lithium-ion batteries.

Enovix is focused initially on batteries for consumer electronics, including smartphones, wearable devices and other mobile products. It has also identified applications in industrial, medical, aerospace, defense and electric vehicle markets.